The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Endocrine Ophthalmopathy: Current Ideas Concerning Etiology, Pathogenesis, and Treatment
Abstract
ALTHOUGH the association of exophthalmos with goiter was recognized as early as the twelfth century (1), the modern focus on the constellation of hyperthyroidism, diffuse goiter, and endocrine ophthalmopathy is best attributed to the work of Caleb Parry (1825) (2), Robert Graves (1835) (3), and Carl von Basedow (1840) (4). Since their early descriptions a plethora of reports have been published detailing the clinical and histologic features of endocrine ophthalmopathy and coining a variety of colorful synonyms and eponyms (5, 6). There remained, however, a number of important unanswered questions. These deal with the nature of the inciting factor, the pathogenesis of the disease, the unique and often asymmetric involvement of extraocular muscles, the relationship between the eye disease and the thyroid abnormality, and the most rational and efficacious methods of treatment. We will review the clinical, anatomic, histologic, and immunologic features of endocrine ophthalmopathy particularly as they apply to these issues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recent studies do not identify a clear sex-related risk for GO (517,518), while some older studies point to a possible slightly increased risk for men (519,520).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [520]
Citations
Cites
Strabismus Ophthalmic Symposium
(1951) · Archives of Ophthalmology · doi:10.1001/archopht.1951.01700020115014 · Cited by 213
Current Topics in Eye Research
(1984) · American Journal of Ophthalmology · doi:10.1016/0002-9394(84)90293-9 · Cited by 46
Hermann, J. S. (1982) · Ophthalmology · doi:10.1016/s0161-6420(82)34775-2 · Cited by 19
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 210
Ohtsuka, K. (2002) · Japanese Journal of Ophthalmology · doi:10.1016/s0021-5155(02)00544-0 · Cited by 20
Acute pre‐tibial myxoedema following radioiodine therapy for thyrotoxic Graves' disease
Harvey, R., Metcalfe, R. A., Morteo, C., Furmaniak, W., Weetman, A. P., & Bevan, J. S. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02695.x · Cited by 20
Autoimmunity in Graves' Ophthalmopathy: A Review
Weetman, A. P. (1989) · Journal of the Royal Society of Medicine · doi:10.1177/014107688908200313 · Cited by 20
Wong, N. T. Y., Yuen, K. F. K., Aljufairi, F. M. A. A., Lai, K. K. H., Hu, Z., Chan, K. K. W., Tham, C. C. Y., Pang, C. P., & Chong, K. K. L. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-03008-x · Cited by 19
Compressive and Infiltrative Optic Neuropathies
Chan, J. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-68979-1_4 · Cited by 19
Tamaki, H., Amino, N., Iwatani, Y., & Miyai, K. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03349918 · Cited by 19
The tear cytokine profile in patients with active Graves’ orbitopathy
Yang, M., Chung, Y., Lang, S. S., Yawata, N., Seah, L. L., & Looi, A. L. G. (2017) · Endocrine · doi:10.1007/s12020-017-1467-2 · Cited by 19
Taoka, T., Sakamoto, M., Nakagawa, H., Fukusumi, A., Iwasaki, S., Taoka, K., & Kichikawa, K. (2005) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000146112.56194.24 · Cited by 18
Yeatts, R. P. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30092-x · Cited by 18
KASHIWAI, T., Tada, H., Asahi, K., Hidaka, Y., Tamaki, H., Iwatani, Y., & Amino, N. (1995) · Endocrine Journal · doi:10.1507/endocrj.42.405 · Cited by 18
Song, D., Wang, R., Zhong, Y., Li, W., Li, H. Y., & Dong, F. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1876-5 · Cited by 17
Krassas, G. E., Pontikides, N., Doukidis, D., Heufelder, G., & Heufelder, A. E. (2001) · Thyroid · doi:10.1089/10507250152740957 · Cited by 17
van Ruyven, R. L. J., van den Bosch, W. A., Mulder, P. G. H., Eijkenboom, W. M. H., & Paridaens, A. D. A. (2000) · Eye · doi:10.1038/eye.2000.199 · Cited by 17
Thrasyvoulides, A., Sakarellos‐Daitsiotis, M., Philippou, G., Souvatzoglou, A., Sakarellos, C., & Lymberi, P. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450119 · Cited by 17
Extraocular Muscle Volumetry for Assessment of Thyroid Eye Disease
Bontzos, G., Papadaki, E., Mazonakis, M., Maris, T. G., Tsakalis, N. G., Drakonaki, E. E., & Detorakis, Ε. T. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001339 · Cited by 17
Hamada, N., Okamoto, Y., YOSHIDA, H., Tsumura, K., Nakamura, Y., & Noh, J. Y. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.623 · Cited by 16
Assessment of disease activity of Graves’ ophthalmopathy
Prummel, M. F., Wiersinga, W. M., & Mourits, M. P. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4647-4_4 · Cited by 16
Treatment of graves' ophthalmopathy with cyclosporin a
Witte, A., Landgraf, R., Markl, A., Boergen, K. ‐., Hasenfratz, G., & Pickardt, C. R. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01737636 · Cited by 16
Diagnosis and Management of Endocrine Ophthalmopathy
Jacobson, D. H., & Carman, C. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31000-8 · Cited by 16
Self-citationDysthyroid optic neuropathy (DON)
Ebner, R. (2002) · Seminars in Ophthalmology · doi:10.1076/soph.17.1.18.10289 · Cited by 15
THE MANAGEMENT OF Graves' OPHTHALMOPATHY
Kendall-Taylor, P. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01296.x · Cited by 15
Contrast sensitivity and the diagnosis dysthyroid optic neuropathy
Mourits, M. P., Suttorp-Schulten, M. S. A., Tijssen, R. O., & Apkarian, P. A. (1990) · Documenta Ophthalmologica · doi:10.1007/bf00145817 · Cited by 14
Kim, W. B., Chung, H. K., Park, Y. J., Park, D. J., Lee, H. K., & Cho, B.-Y. (2001) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2001.16.3.187 · Cited by 14
Immunosuppressive treatment of Graves' ophthalmopathy
Wiersinga, W. M. (1990) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(90)90095-k · Cited by 14
Assessment and Management of the Patient with Graves’ Ophthalmopathy
Bahn, R. S. (1995) · Endocrine Practice · doi:10.4158/ep.1.3.172 · Cited by 14
The Interrelationship Between the Harderian Glands and the Neuroendocrine-Thyroid Axis in Rodents
Buzzell, G. R., & Menéndez-Peláez, A. (1992) · Springer eBooks · doi:10.1007/978-3-642-76685-5_16 · Cited by 14
Computed Tomography Scanning in the Evaluation of Ocular Motility Disorders
Miller, M. T., & Mafee, M. F. (1987) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)02345-4 · Cited by 14
Zhang, Z.-G., Dong, Q., Rodien, P., Alcalde, L., Bernard, N. F., Boucher, A., Salvi, M., Arthurs, B. P., Vassart, G., Ludgate, M. E., et al. (1992) · Autoimmunity · doi:10.3109/08916939209001916 · Cited by 14
Plasma exchange in endocrine ophthalmopathy
Berlin, G., Hjelm, H., Liedén, G., & Tegler, L. (1990) · Journal of Clinical Apheresis · doi:10.1002/jca.2920050405 · Cited by 13
Bromberg, N., Romaldini, J. H., Werner, R. S., Sgarbi, J. A., & WERNER, M. C. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348703 · Cited by 13
Kahaly, G. J., Böckmann, H., Beyer, J., & Bischoff, S. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349564 · Cited by 12
WAKAYAMA, T., Sohmiya, M., FURUYA, H., Murakami, Y., & Kato, Y. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.67 · Cited by 11
Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease
Colao, A., Pivonello, R., Lastoria, S., Faggiano, A., Ferone, D., Lombardi, G., & Fenzi, G. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.143s035 · Cited by 11
Methaemoglobinaemia after peribulbar blockade: an unusual complication in ophthalmic surgery
Eltzschig, H. K. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.4.439e · Cited by 10
Enhanced induction of a 72 kDa heat shock protein in cultured retroocular fibroblasts.
Heufelder, A. E., Wenzel, B. E., & Bahn, R. S. (1992) · PubMed · Cited by 10
Orbital decompression surgery for thyroid eye disease
Stannard, L., Slater, R. M., & Leatherbarrow, B. (2006) · European Journal of Anaesthesiology · doi:10.1017/s0265021505001900 · Cited by 10
Kim, M. R., Faiman, C., Hoogwerf, B. J., & Gupta, M. K. (1997) · Endocrine Practice · doi:10.4158/ep.3.6.337 · Cited by 10
Marco, R. D., Ambrosio, G., & Ferrara, G. (2000) · Documenta Ophthalmologica · doi:10.1023/a:1026557401041 · Cited by 9
Moncayo, R., Moncayo, H., Ulmer, H., & Kainz, H. (2004) · The Journal of Alternative and Complementary Medicine · doi:10.1089/1075553041829479 · Cited by 9
Orbital pathology in thyroid-associated ophthalmopathy
van der Gaag, R., Schmidt, E. D., Zonneveld, F. W., & Koornneef, L. (1996) · Orbit · doi:10.3109/01676839609150228 · Cited by 9
The role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves’ ophthalmopathy
Ortapamuk, H., Hoşal, M. B., & Naldöken, S. (2002) · Annals of Nuclear Medicine · doi:10.1007/bf02988642 · Cited by 7
Kahaly, G. J., Moncayo, R., Stover, C. M., & Beyer, J. (1991) · Research in Experimental Medicine · doi:10.1007/bf02576669 · Cited by 8
Euthyroid graves' disease. ]Report of a case observed over a 12-year period
Peter, S. A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90686-8 · Cited by 8
Profile of lambda light chain variable region genes in graves' orbital tissue
Prummel, M. F., Chazenbalk, G. D., Jaume, J. C., Rapoport, B., & McLachlan, S. M. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90017-5 · Cited by 8
Diagnosis and management of hyperthyroidism
Stockigt, J. R., & Topliss, D. J. (1986) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1986.tb101125.x · Cited by 8
Magnetic Resonance Imaging in Diagnosis and Follow-up of Minimal Thyroid Ophthalmopathy.
Matsuo, H., Motomura, M., Takeo, G., Yoshimura, T., Tsujihata, M., & Nagataki, S. (1991) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.30.229 · Cited by 7
Impairment of Prednisolone Disposition in Patients with Graves' Disease Taking Methimazole*
Legler, U. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-221 · Cited by 7
Thyroid disease and vertical rectus muscle overaction after retrobulbar anesthesia
Han, S. K., & Hwang, J. (2003) · Journal of Cataract & Refractive Surgery · doi:10.1016/s0886-3350(02)01437-2 · Cited by 7
Akamizu, T., Mori, T., Imura, H., Noh, J. Y., Hamada, N., Ito, K., Koizumi, Y., Yamada, T., Fujihira, T., Eto, S., et al. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03350740 · Cited by 7
Penetrating abdominal wound caused by a firework.
Shakil, M., & Smith, J. E. (1987) · BMJ · doi:10.1136/bmj.295.6599.635 · Cited by 6
Thyroid eye disease associated with athyria
Rogers, P. B. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.4.439 · Cited by 6
Cole, A. C. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.4.439a · Cited by 5
Topical Treatment of Elevated Intraocular Pressure in Patients with Graves’ Orbitopathy
Gumińska, M., Goś, R., Śmigielski, J., & Nowak, M. S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249331 · Cited by 5
Krassas, G. E., Pontikides, N., Dumas, A., Frystyk, J., Chen, J., & Flyvbjerg, A. (2004) · HORMONES · doi:10.14310/horm.2002.11126 · Cited by 5
Objective measurement of motion in the orbit
Abràmoff, M. D. (2001) · Cited by 5
Pathophysiology of Graves' Orbitopathy
Smith, T. J., & Douglas, R. S. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50232-0 · Cited by 5
Observations on Graves’ Ophthalmopathy; Pathology and Pathogenesis
Pope, R. M., Ludgate, M. E., & McGregor, A. (1986) · Springer eBooks · doi:10.1007/978-94-009-4171-7_9 · Cited by 5
Li, S., Maes, A., Vermassen, T., Maes, J., Rottey, S., & de Wiele, C. V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238451 · Cited by 6
Treatment of Graves' Orbitopathy in 1990.
Garrity, J. A. (1991) · The Keio Journal of Medicine · doi:10.2302/kjm.40.63 · Cited by 4
Stockigt, J. R., & Topliss, D. J. (1989) · Drugs · doi:10.2165/00003495-198937030-00006 · Cited by 5
Failure to find an association of blood group P1 with thyroid‐associated ophthalmopathy
Weetman, A. P., & Poole, J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02353.x · Cited by 4
The ophthalmopathy of Graves' disease.
Rapoport, D. M. (1985) · Europe PMC (PubMed Central) · Cited by 4
Wuttke, W. (1987) · Springer eBooks · doi:10.1007/978-3-662-09340-5_17 · Cited by 3
Medeiros-Neto, G. A., Zhi-guong-zhang, Lima, N., Iacona, A., Liberman, A., Salvi, M., & Wall, J. R. (1991) · Autoimmunity · doi:10.3109/08916939108997131 · Cited by 3
Volpe, R. J. (1985) · Springer eBooks · doi:10.1007/978-3-642-70607-3_42 · Cited by 3
McDougall, I. R. (1992) · Springer eBooks · doi:10.1007/978-1-4899-2881-8_5 · Cited by 3
Ciclosporin in the Management of Graves’ Ophthalmopathy
McGregor, A., Beck, M., Weetman, A. P., & Hall, R. (1985) · Springer eBooks · doi:10.1007/978-3-642-70607-3_43 · Cited by 3
A study of the binding of Graves’ immunoglobulins to orbital antigens
Banovac, K., Levis, S., & Byrne, S. F. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350165 · Cited by 3
Wiersinga, W. M. (1984) · Orbit · doi:10.3109/01676838409019204 · Cited by 3
Campbell, A. A., & Kazim, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-10886-1_29 · Cited by 2
Barsouk, A., Fraiture, B., Cockerham, K. P., Dalai, M., Nebes, V. L., Stolarski, C., Kennerdell, J. S., Jani, B., & Wall, J. R. (1996) · Orbit · doi:10.3109/01676839609150238 · Cited by 2
Oktreotidszintigraphie zur Diagnose der aktiven endokrinen Orbitopathie
Ardjomand, N., Esche, G., Fellner, P., Lindner, S., Panzitt, M., Aigner, R., & Langmann, A. (2003) · Der Ophthalmologe · doi:10.1007/s00347-003-0807-1 · Cited by 1
The cost of immunosuppressive therapies currently used in patients with thyroid eye disease
Krassas, G. E. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347533 · Cited by 2
Treatment of Graves’ Ophthalmopathy with Ciclosporin
Landgraf, R., Witte, A., Markl, A., Boergen, K. ‐., Hasenfratz, G., & Pickardt, C. R. (1985) · Springer eBooks · doi:10.1007/978-3-642-70607-3_44 · Cited by 2
Marcocci, C., Bartalena, L., Panicucci, M., Cavallacci, G., Marconcini, C., Lepri, A., Laddaga, M., Cartei, F., & Pinchera, A. (1987) · Springer eBooks · doi:10.1007/978-1-4613-0945-1_101 · Cited by 1
Compressive and Infiltrative Optic Neuropathies
Chan, J. W. (2014) · Springer eBooks · doi:10.1007/978-1-4614-0691-4_4 · Cited by 1
Wang, Y., & Douglas, R. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_61 · Cited by 1
Looking for gall bladder disease in the patient's iris
(1997) · Complementary Therapies in Medicine · doi:10.1016/s0965-2299(97)80108-2 · Cited by 1
dos Santos, R. B. (2009) · doi:10.47749/t/unicamp.2009.439872 · Cited by 1
The site of the autoantigen in dysthyroid eye disease: A significant negative
Foss, A. J. E., Fisher, E. W., McDonald, N., Lawson, J., Gregson, R., & Fells, P. (1993) · Eye · doi:10.1038/eye.1993.189 · Cited by 1
Free conjunctival autograft harvested from the fornix for repair of leaking blebs
Miyazawa, D. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.4.439b · Cited by 1
Treatment of 1035 Hyperthyroid Patients with 131Iodine
., M.-H. B., Larijani, B. A., Rahim-Tabrizi, P., ., A.-R. K.-F., & Baradar-Jalili, R. (2005) · International Journal of Pharmacology · doi:10.3923/ijp.2006.116.120 · Cited by 1
Somatostatin in the Treatment of Thyroid Eye Disease
Krassas, G. E. (2002) · CRC Press eBooks · doi:10.3109/9780203908983-43 · Cited by 1
Volpe, R. J. (1990) · Elsevier eBooks · doi:10.1016/b978-0-7216-2190-6.50017-0 · Cited by 1
Wuttke, W. (1989) · Springer eBooks · doi:10.1007/978-3-642-73831-9_17 · Cited by 1
Wuttke, W. (1995) · Springer-Lehrbuch · doi:10.1007/978-3-662-09334-4_20 · Cited by 1
Plasma exchange therapy for severe Graves' ophthalmopathy
Schrooyen, M., WINAND, R. J., & Glinoer, D. (1986) · Orbit · doi:10.3109/01676838609034246
Petruson, B., & Frisén, L. (1990) · Clinical Otolaryngology · doi:10.1111/j.1365-2273.1990.tb00454.x
Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report
Ferracci, F., Conte, F., Marini, B., & Fassetta, G. (1997) · Neurological Sciences · doi:10.1007/bf02080466
Características Clínico-Epidemiológicas de la Oftalmopatía de Graves: Significado Etiopatogénico
Garrido, E. (2014) · Anales de la Facultad de Medicina · doi:10.15381/anales.v61i1.4247
Development of an instrument for the early detection of thyroid orbitopathy
Linder, M. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0089582
Management of Thyroid Eye Disease
Fells, P. (1993) · Elsevier eBooks · doi:10.1016/b978-0-7506-1390-3.50030-1
Kanski, J. J., & Thomas, D. J. (1990) · Elsevier eBooks · doi:10.1016/b978-0-7506-1024-7.50006-x
Imaging inflammatory lesions by radiolabelled peptides and antibodies
Fuentes, L. K. A. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.132148854
Sune, M. P., & Sune, P. G. (2013) · Highlights of Ophthalmology · doi:10.5005/hos-10101-41304
Sune, M. P., & Sune, P. G. (2013) · Highlights of Ophthalmology · doi:10.5005/hoo-10101-41303
Pedrosa, P., Neidl, K., Higer, H., Utech, C., Wulle, K. G., & Pfannenstiel, P. (1990) · Springer eBooks · doi:10.1007/978-3-642-74993-3_49
Wuttke, W. (2000) · Springer-Lehrbuch · doi:10.1007/978-3-662-09346-7_20
Metadata
- Authors
- JACOBSON, D. H., & GORMAN, C. A.
- Affiliations
- Mayo Clinic (US)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1984-04
- Volume
- 5
- Issue
- 2
- Pages
- 200-220
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1965113827
- Cited by
- 211
- References
- 3
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2017: 1 · 2016: 4 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- Graves' ophthalmopathy, endocrine ophthalmopathy, hyperthyroidism, goiter, proptosis, pathogenesis, etiology, extraocular muscles, thyroid autoimmunity, treatment
- MeSH terms
- Adolescent, Adult, Aged, Autoimmune Diseases, Child, Graves Disease, Humans, Middle Aged, Oculomotor Muscles, Orbit, Thyroid Gland, Thyroidectomy, Tomography, X-Ray Computed, Ultrasonography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review